New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis Sepsis and antimicrobial resistance (AMR) account for growing numbers of deaths and healthcare costs worldwide. It is believed that sepsis causes over 5 million deaths annually. One report predicts that AMR could cause over 10 million deaths globally per year by 2050. Both [...]
Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis.
We’re seeking teammates with expertise, curiosity and passion for solving clinical challenges with a focus on patient outcomes. If that sounds like you, check out our Careers Page.
© Copyright, Inflammatix, Inc. All Rights Reserved | Terms & Conditions | Privacy & Cookies Statement
Inflammatix, TriVerity, Myrna, and BacVerity are trademarks of Inflammatix, Inc.
